The Discounted Cash Flow (DCF) valuation of Dr Sulaiman Al-Habib Medical Services Group Co (4013.SR) is 138.03 SAR. With the latest stock price at 265.00 SAR, the upside of Dr Sulaiman Al-Habib Medical Services Group Co based on DCF is -47.9%.
Based on the latest price of 265.00 SAR and our DCF valuation, Dr Sulaiman Al-Habib Medical Services Group Co (4013.SR) is a sell. selling 4013.SR stocks now will result in a potential gain of 47.9%.
| Range | Selected | |
| WACC / Discount Rate | 11.6% - 14.2% | 12.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 108.95 - 187.45 | 138.03 |
| Upside | -58.9% - -29.3% | -47.9% |